Shares of Immunovant, Alto and Oric Pharmaceuticals fell this week on clinical trial updates. Elsewhere, Orca Bio’s cell therapy hit a delay and Korsana entered a reverse merger.
Continue reading →
In an interview, Chief Financial Officer Robin Kramer said the combined cash flow from Biogen and Apellis will not only help debt leverage ratios but also free up capacity to do other strategic deals.
Continue reading →
The Host Julie Rovner KFF Health News @jrovner @julierovner.bsky.social Read Julie’s stories. Julie Rovner is chief Washington correspondent and host of KFF Health News’ weekly health policy news podcast, “What the Health?” A noted expert on health policy issues, Julie is...
Many Americans—regardless of party—espoused evolving views on the nature of America’s relationships with China, Canada and Mexico, its top three trading partners.
Continue reading →
Two-thirds of students reported feeling unsafe because of their LGBTQ+ identity in 2024-25, according to data from an annual survey by Glisten.
Continue reading →
District leaders will face questions from families who receive settlement notices as ed tech pushback grows, a K-12 cybersecurity expert says.
Continue reading →